Latest Intelligence on Infectious Diseases in Europe

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
ResearchWire
ResearchWire

Hepatitis B: improved antivirals and disease awareness drive rapid market growth

Published By Datamonitor
14 May 2008
CommentWire
CommentWire

Hepatitis B: the time is right for UK vaccination

According the British Medical Association (BMA), all children in the UK should be immunized against the hepatitis B virus. There were 1,151 new cases diagnosed in 2003, a 135% increase since 1992, suggesting a marked rise in infection rates. While faith in mass vaccination in the UK was shaken by the MMR debacle, on this evidence mass childhood vaccination for hepatitis B is overdue.

Published By Datamonitor
10 May 2005
ResearchWire
ResearchWire

Hepatitis C: protease inhibitors to drive market expansion

Published By Datamonitor
21 Jul 2006
CommentWire
CommentWire

Hepatitis immunization: study slams French policy

The French government has come under severe criticism for its failure to effectively monitor the safety of hepatitis B immunization programs. Since maintaining public confidence in immunization programs is vital to both national health and vaccine profitability, other governments should learn from France's mistakes.

Published By Datamonitor
20 Nov 2002
CommentWire
CommentWire

Herpes: infra-red light may cure cold sores

The new device could prove a more efficacious therapy than currently marketed drugs, creating a threat to sales of GSK and Novartis' market leading drugs. However, it is unlikely to take off if patients have to get a doctors' appointment to use it. Home self-treatment kits will be required for market success.

Published By Datamonitor
09 Apr 2002
Expert View
Expert View

HIV market: collaborative combinations

Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 and elvitegravir are set to compete head-to-head against more widely-used competitors. In the longer term, both candidates could improve usage and penetration through use in collaborative combination therapies.

Published By Datamonitor
12 Mar 2007
ResearchWire
ResearchWire

HIV market: set to undergo dramatic changes over next decade

Published By Datamonitor
05 Oct 2007
ResearchWire
ResearchWire

HIV/AIDS: compliance rates will improve across the globe

Published By Datamonitor
14 Aug 2001
ResearchWire
ResearchWire

HIV/AIDS: number of treated patients in Japan will double by 2007

Published By Datamonitor
14 Jan 2002
ResearchWire
ResearchWire

HIV/AIDS: UK leads the way in diagnoses

Published By Datamonitor
09 Nov 2004

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.